Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10977820 | PMC |
http://dx.doi.org/10.3201/eid3004.231361 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!